Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Balloon Sinuplasty Helps Chronic Sinusitis Patients

By HospiMedica staff writers
Posted on 21 Apr 2008
Balloon sinuplasty technology safely opens narrow sinuses, is economical, and is highly satisfactory to chronic sinusitis patients, according to a new study.

Researchers at the Cleveland Nasal, Sinus and Sleep Center (OH, USA) and other institutions conducted a multicenter registry study of balloon catheter-sinusotomy outcomes for 1036 patients. More...
The data were collected by standardized chart review with centralized database administration for all consecutive functional endoscopic sinus surgeries that included the use of balloon catheters across the 18-month period from December 2005 to May 2007. The study results showed that balloon catheters were used in 3276 peripheral (maxillary, frontal, and sphenoid) sinuses, for an average of 3.2 sinuses per patient. The revision rate was 1.3% of sinuses treated with a balloon catheter after an average follow-up of 40.2 weeks. The researchers found that sinus symptoms were improved in 95.2%, unchanged in 3.8%, and worse in 1.0% of patients. Postoperative sinus infections were significantly less frequent and less severe compared to infections before surgery. The results were consistent across all patient categories, including balloon-only patients and revision patients. No adverse events were attributable to balloon sinuplasty. The study was published in the April 2008 issue of Annals of Otology, Rhinology, & Laryngology.

"The results from this study reinforce the outstanding safety record of balloon sinuplasty technology, and underscore its effectiveness in alleviating chronic sinusitis symptoms,” said lead author Howard Levine, M.D., director of the Cleveland Nasal, Sinus, and Sleep Center. "Results were universally excellent across a large population of patients and dozens of different practices.”

Balloon sinuplasty, a technology developed by Acclarent (Menlo Park, CA, USA), is similar in concept to catheters used for cardiac balloon angioplasty. The specially designed devices are threaded into the sinus passageways and gently inflated, widening the passages to promote drainage and resolution of chronic sinusitis symptoms. The technology can be used as a stand-alone system or with standard surgical instrumentation. Recovery times vary, but patients typically return to normal activities within 24 hours of treatment.

Chronic sinusitis is an inflammation of the nasal sinuses afflicting an estimated 37 million people annually in the United States alone. Symptoms include facial pain or pressure, nasal discharge, difficulty breathing through the nose, and fatigue. Although antibiotics and topical steroids can help many people, approximately 500,000 U.S. patients undergo surgery each year to alleviate the symptoms of chronic sinusitis.


Related Links:
Cleveland Nasal, Sinus, and Sleep Center
Acclarent

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.